US 11103552
High concentration VEGF receptor fusion protein containing formulations
granted A61KA61K38/179A61K39/39591
Quick answer
US patent 11103552 (High concentration VEGF receptor fusion protein containing formulations) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K38/179, A61K39/39591, A61K47/12, A61K47/183